Windsor, CA, United States of America

Hezi-Yamit Ayala


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hezi-Yamit Ayala: Innovator in Cardiovascular Treatments

Introduction

Hezi-Yamit Ayala is a notable inventor based in Windsor, CA (US). He has made significant contributions to the field of cardiovascular medicine, holding 2 patents that focus on innovative treatments for damaged cardiovascular elements.

Latest Patents

His latest patents include compositions and methods for treating damaged cardiovascular elements. These inventions address various cardiovascular conditions such as hypotension, atherosclerotic lesions, vulnerable plaque, and acute myocardial infarction. The patents demonstrate the effectiveness of a biomembrane sealing agent that accumulates on the walls of damaged blood vessels, improving mean arterial pressure following tissue injury. The formulations described in his patents comprise at least one biomembrane sealing agent and one bioactive agent, which can be administered either concurrently with invasive therapeutic interventions or post-injury. These methods aim to reduce the severity of cardiovascular diseases after their onset.

Career Highlights

Hezi-Yamit Ayala is associated with Warsaw Orthopedic, Inc., where he continues to develop innovative solutions in the medical field. His work has the potential to significantly impact the treatment of cardiovascular diseases, providing new avenues for patient care.

Collaborations

Hezi-Yamit collaborates with talented professionals such as Josee Roy and Carol Sullivan, contributing to a dynamic team focused on advancing medical technology.

Conclusion

Hezi-Yamit Ayala's contributions to cardiovascular treatment through his patents reflect his commitment to innovation in medicine. His work is paving the way for improved therapeutic options for patients suffering from cardiovascular conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…